What is the most recent earnings date for JAGX stock?
JAGUAR HEALTH INC (JAGX) last reported earnings on 4/7/2026.
NASDAQ:JAGX • US47010C8881
Past quarterly earnings results for JAGUAR HEALTH INC (JAGX), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -4.35 | - | -1,178.00% | 3.235M | 4.295M | -24.68% | -6.64% | |
| Q3 2025 | -6.28 | -5.18 | -21.20% | 76.08% | 3.083M | 3.805M | -18.98% | -0.80% |
| Q2 2025 | -10.26 | -7.27 | -41.08% | 89.84% | 2.936M | 3.33M | -11.83% | 7.90% |
| Q1 2025 | -16.70 | -18.36 | 9.04% | 84.10% | 2.214M | 2.877M | -23.04% | -5.83% |
| Q4 2024 | -0.34 | -18.87 | 98.20% | 65.99% | 3.465M | 3.193M | 8.52% | 50.65% |
| Q3 2024 | -26.25 | -60.44 | 56.56% | 96.82% | 3.108M | 4.017M | -22.63% | 10.49% |
| Q2 2024 | -101.00 | -30.60 | -230.07% | 90.24% | 2.721M | 3.494M | -22.12% | 1.68% |
| Q1 2024 | -105.00 | -45.90 | -128.76% | -171,468.63% | 2.351M | 3.017M | -22.07% | 19.22% |
| Q4 2023 | -1.00 | - | 89.95% | 2.3M | 2.662M | -13.60% | -29.45% | |
| Q3 2023 | -825.00 | -1,881.90 | 56.16% | 93.89% | 2.813M | 2.509M | 12.12% | -10.70% |
| Q2 2023 | -1,035.00 | -2,340.90 | 55.79% | 92.33% | 2.676M | 2.326M | 15.05% | -8.39% |
| Q1 2023 | -0.06 | - | 100.00% | 1.972M | 3.978M | -50.43% | -24.88% | |
| Q4 2022 | -9.95 | - | 99.97% | 3.26M | 2.04M | 59.80% | 56.73% | |
| Q3 2022 | -13,500.00 | -8,606.25 | -56.86% | 55.56% | 3.15M | 3.621M | -13.01% | 400.00% |
| Q2 2022 | -13,500.00 | -25,245.00 | 46.52% | 60.00% | 2.921M | 3.162M | -7.62% | 658.70% |
| Q1 2022 | -45,000.00 | -20,081.25 | -124.09% | -33.33% | 2.625M | 1.652M | 58.90% | 111.52% |
| Q4 2021 | -34,875.00 | -10,327.50 | -237.69% | 31.11% | 2.08M | 8.548M | -75.67% | -19.25% |
| Q3 2021 | -30,375.00 | -20,081.25 | -51.26% | 57.14% | 630K | 2.683M | -76.52% | -77.28% |
| Q2 2021 | -33,750.00 | -13,770.00 | -145.10% | 65.52% | 385K | 5.049M | -92.37% | -87.84% |
| Q1 2021 | -33,750.00 | -6,885.00 | -390.20% | 77.78% | 1.241M | 7.548M | -83.56% | 42.81% |
| Q4 2020 | -50,625.00 | -34,425.00 | -47.06% | - | 2.576M | 2.346M | 9.80% | - |
| Q3 2020 | -70,875.00 | -37,867.50 | -87.17% | - | 2.773M | 7.956M | -65.15% | - |
| Q2 2020 | -97,875.00 | -51,637.50 | -89.54% | - | 3.167M | 4.874M | -35.02% | - |
| Q1 2020 | -151,875.00 | -79,177.50 | -91.82% | - | 869K | 2.545M | -65.85% | - |
Notes
JAGUAR HEALTH INC (JAGX) last reported earnings on 4/7/2026.
JAGUAR HEALTH INC (JAGX) missed EPS estimates and missed revenue estimates in the most recent quarter.